Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus music intervention for intraoperative sedation during TURP under spinal anesthesia
ChiCTR2300071284Phase 4Not yet recruiting
- Sponsor
- Liaoning Provincial People's Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam in benign prostatic hyperplasia (BPH) (4 arms), sponsored by Liaoning Provincial People's Hospital. Primary endpoint: Bispectral index. Planned start May 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR2300071284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071284.